Last reviewed · How we verify

NCT06896318

Virtual Reality-Supported Cardiac Rehabilitation: Psychological, Functional, and Physiological Perspectives

Active, enrolled NA Last updated 24 June 2025
What this trial tests

NA trial testing Virtual Reality Therapy in Cardiovascular Diseases in 60 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 April 2025
Primary endpoint
31 December 2025
30 June 2026

Quick facts

Lead sponsorWroclaw University of Health and Sport Sciences
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date1 April 2025
Primary completion31 December 2025
Estimated completion30 June 2026
Sites2 locations across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Wroclaw University of Health and Sport Sciences

Who can join

Adults 60 Months to 85, any sex, with Cardiovascular Diseases or Coronary Arterial Disease (CAD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to evaluate the effectiveness of virtual reality-assisted cardiac rehabilitation compared to conventional cardiac rehabilitation in improving psychological outcomes-depression, stress, anxiety, and kinesiophobia-along with physiological parameters, functional status, physical activity levels, and quality of life in cardiac patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Virtual Reality Therapy

Trials testing the same drug.

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Other Wroclaw University of Health and Sport Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06896318.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing